Last reviewed · How we verify
NCT04102306: TMIQ
Assessing Motor Imagery Ability of Tongue and Mouth in Subjects With and With no Temporomandibular Disorders
trial testing reliability and validity construct of the TMIQ in Temporomandibular Disorder in 94 participants. Completed in 31 December 2019.
31 December 2019
Quick facts
| Lead sponsor | Cabinet de Kinesitherapie SCM Saint-Alexandre |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 94 |
| Start date | 26 September 2018 |
| Primary completion | 31 December 2019 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across France |
Drugs / interventions tested
- reliability and validity construct of the TMIQ
Conditions studied
- Temporomandibular Disorder — all drugs for Temporomandibular Disorder →
- Motor Imagery — all drugs for Motor Imagery →
Sponsor
Cabinet de Kinesitherapie SCM Saint-Alexandre
Who can join
Adults 18 to 75, any sex, with Temporomandibular Disorder or Motor Imagery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Temporomandibular disorder (TMD) is the symptomatic expression of a muscular or an articular impairment at the manducatory tract. TMD affects between 30 to 65% of the population with a higher prevalence for young women. The patients with DTM report a decrease of their personal, social and professional quality of life. Treatment usually relies on physical therapy. Among the different technics that can be used in physical therapy, there is growing evidence advocating the efficacy of using motor imagery (i.e. imagining a movement with no concomitant physical execution) during rehabilitation. It has also been shown that the benefits of practicing motor imagery depend on the ability (i.e., the higher the ability, the greater the benefits). However, there is no investigation of the motor imagery ability of the tongue and mouth movements conditioning the use of motor imagery during TMD rehabilitation. The objective of the study is to investigate the ability of imagining tongue and mouth movements using the Tongue and Mouth Imagery Questionnaire (TMIQ) as compare to the gold-standard Kinesthetic and Visual Imagery Questionnaire (KVIQ - Malouin et al., 2007).
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Impaired tongue motor control after temporomandibular disorder: A proof-of-concept case-control study of tongue print.
Alvarado C, Arminjon A, Damieux-Verdeaux C, Lhotte C, et al · · 2022 · cited 3× · PMID 35220688 · DOI 10.1002/cre2.549 -
Tongue and mouth imagery questionnaire (TMIQ) for assessing motor imagery vividness of the temporomandibular region: A reliability and validity case-control study.
Alvarado C, Arminjon A, Damieux-Verdeaux C, Lhotte C, et al · · 2022 · cited 3× · PMID 35108417 · DOI 10.1111/joor.13309
Verify or expand the search:
- PubMed search for NCT04102306
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Temporomandibular Disorder
Currently open trials in the same condition.
- NCT06941636 — Botulinumtoxin A as a Treatment for Myalgia and Myofacial Pain in Patient With Temporomandibulardisorders · Phase 3 · recruiting
- NCT03849534 — Treatment of Temporomandibular Disorders in Children and Adolsecents · NA · recruiting
- NCT06214923 — Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG) · NA · recruiting
- NCT06365151 — An Algorithm for Approaching Temporomandibular Disorders With Osteopathic Manual Therapy in Patients With Fibromyalgia · NA · recruiting
- NCT06357702 — K23- Physical Self Regulation vs Placebo · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04102306 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cabinet de Kinesitherapie SCM Saint-Alexandre
- Last refreshed: 6 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04102306.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing